Results 181 to 190 of about 13,569 (208)

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial

Lancet, The, 2001
M. Simoons
exaly   +2 more sources

Emergent carotid stenting and intra-arterial abciximab in acute ischemic stroke due to tandem occlusion

British Journal of Neurosurgery, 2017
F. Al-Mufti, K. Amuluru, N. Manning, I. Khan, L. Peeling, C. Gandhi, C. Prestigiacomo, Galyna Pushchinska, D. Fiorella, H. Woo   +9 more
semanticscholar   +1 more source

Intra-Arterial Use of Abciximab in Thromboembolic Complications Associated with Cerebral Aneurysm Coiling: The London Ontario Experience.

World Neurosurgery, 2017
R. Martínez-Pérez, S. Lownie, D. Pelz
semanticscholar   +1 more source

How abciximab might be clinically useful.

International Journal of Cardiology, 2016
C. Usta, N. Turgut, Aslı Bedel
semanticscholar   +1 more source

Management of coronary artery aneurysms using abciximab in children with Kawasaki disease.

International Journal of Cardiology, 2016
E. Bachlava, Sophia Loukopoulou, E. Karanasios, G. Chrousos, Athanasios Michos   +4 more
semanticscholar   +1 more source

Randomized evaluation of intralesion versus intracoronary abciximab and aspiration thrombectomy in patients with ST-elevation myocardial infarction: The COCTAIL II trial.

American Heart Journal, 2015
F. Prati, E. Romagnoli, U. Limbruno, T. Pawlowski, S. Fedele, L. Gatto, L. Di Vito, A. Pappalardo, V. Ramazzotti, A. Picchi, A. Trivisonno, Laura Materia, Piotre Pfiatkosky, G. Paoletti, V. Marco, L. Tavazzi, F. Versaci, G. Stone   +17 more
semanticscholar   +1 more source

αIIbβ3-integrin Ligands: Abciximab and Eptifibatide as Proapoptotic Factors in MCF-7 Human Breast Cancer Cells.

Current Drug Targets, 2015
J. Konończuk, A. Surażyński, U. Czyżewska, Izabela Prokop, M. Tomczyk, J. Pałka, W. Miltyk   +6 more
semanticscholar   +1 more source

Intraprocedural abciximab bolus versus pretreatment oral dual antiplatelet medication for endovascular stenting of unruptured intracranial aneurysms

Journal of NeuroInterventional Surgery, 2015
M. Levitt, K. Moon, F. Albuquerque, C. Mulholland, M. Kalani, C. McDougall   +5 more
semanticscholar   +1 more source

Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial.

Journal of the American Medical Association (JAMA), 2006
A. Kastrati, J. Mehilli, F. Neumann, F. Dotzer, J. T. ten Berg, H. Bollwein, Isolde Graf, Maryam Ibrahim, J. Pache, M. Seyfarth, H. Schühlen, J. Dirschinger, P. Berger, A. Schömig   +13 more
semanticscholar   +1 more source

Intracoronary abciximab in diabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Vascular pharmacology, 2015
R. Piccolo, I. Eitel, G. Galasso, A. Iversen, Youlan L. Gu, A. Domínguez-Rodríguez, B. D. de Smet, K. Mahmoud, P. Abreu-González, H. Thiele, F. Piscione   +10 more
semanticscholar   +1 more source